Ad
related to: astrazeneca stock- Trade
Buy, sell, track the market.
Discover our investment products.
- Ranked #1 in Research
Kiplinger's Best Online Brokers
Annual Review from August 31, 2023
- Open an Account
Choose The Account That Works
Best For You, and Start Investing
- Learn How To Trade
We can help you invest with speed
& accuracy at every step of a trade
- Trade
Search results
Astrazeneca (AZN) Beats Stock Market Upswing: What Investors Need to Know
Zacks via Yahoo Finance· 1 day agoIt is also important to note the recent changes to analyst estimates for Astrazeneca. Recent...
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock? | The Motley Fool
The Motley Fool· 7 days agoAstraZeneca (AZN -0.70%) is embarking on a fresh business plan that will see it grow significantly...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
The Motley Fool via AOL· 7 days agoAnd there's nothing that's more core to a pharma business than a healthy pipeline. So, based on...
AstraZeneca PLC (NASDAQ:AZN) Stock Holdings Lifted by Hsbc Holdings PLC
ETF DAILY NEWS· 6 days agoHsbc Holdings PLC raised its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 13.7% during the fourth quarter, according to its most recent Form 13F filing with the ...
AstraZeneca stock upgraded by Goldman, 27% upside seen By Investing.com
Investing.com· 6 days agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN)...
AstraZeneca started at buy at Goldman, which rates GSK a neutral
Market Watch· 6 days agoGoldman Sachs started coverage of AstraZeneca at buy as it rated rival pharmaceutical company GSK a...
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
Motley Fool via Yahoo Finance· 6 days agoAstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company...
3 No-Brainer Stocks to Buy in June
Motley Fool via Yahoo Finance· 3 days agoTrading at 18 times its expected future earnings, the stock's valuation is attractive when compared to the average healthcare stock, which trades at a...
Cramer's Lighting Round: 'You've got a winner' with Astra Zeneca
CNBC· 4 days ago"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to...
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 5 days agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...
Ad
related to: astrazeneca stock
